In a study conducted on mice with AD, the administration of Xanthoceraside significantly decreased the expression of pGSK-3β and tau protein at Ser396 and Ser404, thereby effectively inhibiting the phosphorylation of tau protein [59]. Here, MAPT is linked to Alzheimer disease.